even at a dose of 10 ng. In the rat ischemia model, stau rosporine (10 ng) also prevented neuronal damage when administered before ischemic insult, although staurospo rine administered 10 or 180 min after recirculation was ineffective. These results suggest the involvement of PKC in CAl pyramidal cell death after ischemia and that the fate of vulnerable CAl pyramidal cells through PKC mediated processes could be determined during the early recirculation period. Key Words: Cerebral ischemia Cyclic nucleotide-dependent protein kinase-Hippo campus-Protein kinase C-Selective vulnerability Staurosporine.
operated calcium channels (Izumiyama and Ko gure, 1988) .
Protein kinase C (PKC) is a Ca 2 + -and phospho lipid-dependent enzyme highly concentrated in the brain (Kikkawa et aI., 1982) . The activation of PKC plays a critical role in neurotransmitter release and synaptic plasticity (Malenka et aI., 1986; Nishizuka, 1986) . Immunohistochemical localization of PKC (Saito et aI., 1988) and phorbol ester autoradiogra phy (Worley et aI., 1986) revealed that the hippo campus contains a high concentration of PKC mol ecules in the brain, with the highest density in the CAl subfield, where selective pyramidal cell death is observed after ischemia. Hydrolysis of phosphoi nositides into diacylglycerol and inositol phos phates, which was observed after ischemia (Abe et aI., 1987) , may modulate protein phosphorylation via PKC (Gonzales et aI., 1987) . We reported that phorbol ester binding in the dendritic fields of the CAl subregion increased during early recirculation and reached a maximum 6-12 h after ischemia (On odera et aI., 1989) . Consequently, this enzyme may play a pivotal role in the postischemic modulation of synaptic efficacy in the hippocampal formation and neuronal death of CAl pyramidal cells. How ever, the postischemic changes and the roles of in tracellular signal transduction systems, such as PKC, cyclic neucleotide-dependent protein ki nases, and calmodulin, are not well known.
The aim of the present study was to clarify the contribution of protein kinases to the ischemic death of CAl pyramidal cells. The protective effects of protein kinase inhibitors and calmodulin kinase inhibitor W-7 (Hidaka et al., 1978) against ischemic neuronal damage were estimated in the CAl sub field of the hippocampus. We estimated the neuro nal damage by means of histopathology and immu nohistochemistry of microtuble-associated protein 2 (MAP2), a marker protein of dendrites (Matus et al., 198 1; Caceres et aI., 1983; Bernhardt and Ma tus, 1984) . Staurosporine (Tamaoki et al., 1986) , KT5720 (Kase et al., 1987) , and KT5822 (Kase et al., 1987) were used as inhibitors of PKC, cyclic AMP-dependent protein kinase, and cyclic GMP dependent protein kinase, respectively. Mongolian gerbils have been commonly used to estimate the protective effects of drugs against ischemic CAl py ramidal cell damage (Kirino, 1982; Kirino et al., 1986a,b; Gill et al., 1987; Izumiyama and Kogure, 1988) , although involvement of the hippocampus in the seizure activities characteristic of this animal has been reported (Paul et al., 198 1; Peterson et al., 1985) . Interestingly, the protective effect of drugs against ischemic CAl damage is more pronounced in gerbil models than rat models. Drugs with anti epileptic potency may be beneficial to protect against CA I pyramidal cell damage in the gerbil ischemia model (Kirino et al., 1986b; Taft et aI., 1989) . Therefore, we used both rat and gerbil isch emia models to estimate the protective role of stau rosporine against ischemic death of CAl pyramidal cells.
MATERIALS AND METHODS

Gerbil model
Male Mongolian gerbils weighing 60-80 g each were divided into eight groups at random; no selection criteria were used for attributing the animals to the various groups. The animals were anesthetized (2% halothane, 70% NzO, 30% Oz) and mounted on a stereotaxic appa ratus. Thereafter anesthesia was maintained with 1% halothane. One microliter of vehicle (5% dimethyl sulf oxide in saline) or test compounds was stereotaxically administered into the bilateral CAl subfield of the hippo campus over a period of 10 min, according to the atlas of Loskota et al. (1974) . The site was 1.8 mm posterior to bregma, 2.0 mm lateral to the midline, and 1.4 mm into the dural surface. In sham-operated animals, the cannu lation was made but neither injection nor ischemia was induced. Thirty minutes after the righting reflex was re gained, both common carotid arteries were exposed un der 1 % halothane anesthesia. After completion of the sur gical procedures, halothane was discontinued, and 2 min later both carotid arteries were clipped for 5 min. The body temperature of the animals was maintained at 37°C using a heating pad with thermostat and a heating lamp during the operation period and until righting reflex reap peared, because hypothermia acts protectively against the postischemic neuronal damage Moller et aI., 1989) . Seven days after ischemia, the ani mals were perfused transcardially with heparinized saline followed by 10% formalin under deep pentobarbital anes thesia. The brains were removed and embedded in paraf fin using standard procedures. Coronal sections (5 fLm thick) containing the needle tract were stained with cresyl violet, and the number of neurons in the linear length (1 mm) of the stratum pyramidale of the hippocampal CAl subfield (neuronal cell density) was counted in each spec imen, according to the method of Kirino et aI., (1986a) . The linear length of the CAl subfield was measured with a digitizer (Wacom Co.).
Immunohistochemistry
Some coronal sections, 5 fLm thick, in the gerbil model were immunostained with a monoclonal antibody to MAP2 (1:1,000; Sigma, St. Louis, MO, U.S.A.) for 2 h at room temperature. An anti-mouse avidin-biotinylated horseradish peroxidase kit was used according to the sup plier's recommendations (Vector Labs) and the sections reacted with 3,3-diaminobenzidine tetrahydrochloride. Staurosporine (10 ng/body) was administered 30 min prior to ischemia.
Rat model
Male Wistar rats (250-300 g) were used and divided into six groups at random. Transient forebrain ischemia was induced according to the method of Pulsinelli et al. (1982) . Briefly, the animals were anesthetized with pentobarbital (50 mg/kg i.p.) and both vertebral arteries were electro cauterized. The next day the common carotid arteries were exposed under 1 % halothane in a mixture of 70% NzO and 30% Oz. After completion of the surgical pro cedure, the halothane was discontinued, and 2 min later both common carotid arteries were clamped using aneu rysm clips for 20 min. Topical injection into the CAl sub field (2 fLI) of vehicle (5% dimethyl sulfoxide in saline) or staurosporine dissolved in the vehicle was carried out unilaterally over a period of 4 min, and the needle was left for 2 min. Staurosporine was administered before isch emia (30 min) or after ischemia (10 or 180 min) through a 27-gauge stainless-steel needle. Coordination was as fol lows: 3.6 mm posterior to bregma, 1.9 mm lateral to the midline, and 2.8 mm from the dural surface, according to the atlas of Paxinos and Watson (1986) . The body tem perature of the animals was maintained at 37°C using a heating pad with thermostat and a heating lamp during the operation period and until righting reflex reappeared. The animals were perfusion-fixed and stained 7 days after ischemia as described above.
Cellular distribution
PC12 cells were collected 15 min and 2, 8, and 24 h after I-h incubation with 200 nM staurosporine and washed by centrifugation. The resultant pellet was dissolved in N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid buffer (pH 7.4) and sonicated for 20 s with a Tomy Seiko Ultrasonic Disruptor (UR-200P). The preparation was centrifuged for 10 min at 19,000 g. The staurosporine present in the supernatant was extracted with chloroform! methanol (9: 1, vol/vol). The extracts were concentrated in vacuo and dissolved in 100 ILl of dimethyl sulfoxide followed by dilution with N-2-hydroxyethyl-piperazine N' -2-ethanesulfonic acid buffer. The amount of stauro sporine was determined with a fluorescence spectropho tometer (F-3000; Hitachi) at an excitation wavelength of 290 nm and emission wavelength of 300-550 nm. The staurosporine in the culture medium was also extracted and measured. Positive control reaction was done in a similar manner with fluorescein diacetate, which is known to cross the cell membrane.
Test compounds
Staurosporine, KT5720, and KT5822 were gifts from Kyowa Hakko Kogyo Co. Ltd. (Japan). W-7 and mono clonal antibody of MAP2 were obtained from Sigma.
Statistics
Statistical comparisons were made by the Kruskal Wallis one-way analysis of variance, two-tailed Mann Whitney U test, and paired t test.
RESULTS
Gerbil model ( Table 1 , Fig. 1) In the sham-operated group (cannulated in the CAl without ischemia or injection), the neuronal cell density of the CAl subfield was 246 ± 23/mm (mean ± SD, n = 12). In the ischemia group (with vehicle injection), the number of CAl pyramidal cells was markedly decreased (81 ± 47/mm, n = 13), which was statistically significant (p < 0.01).
Staurosporine (0.1, 1, and 10 ng) administered 30 min preceding transient ischemia, in a dose-depen dent manner significantly (p < 0.01) protected against pyramidal cell loss in the CAl subfield at a concentration of 1 and 10 ng. On the other hand, KT5720, KT5822, and W-7 had no protective effect on postischemic CAl pyramidal cell death. Immunohistochemistry (Fig. 2) MAP2 immunohistochemistry, which provides a marker protein of dendrites, revealed that MAP2 immunoreactivity in hippocampus pretreated with staurosporine was similar to that of sham-operated animals, although animals without staurosporine had a marked decrease in MAP2 immunoreactivity.
Rat model (Table 2, Fig. 3) In the sham-operated group, the neuronal cell densities of the CAl subfield were 165 ± 18/mm (ipsilateral side, n = 6) and 174 ± 13/mm (contra lateral side, n = 6). In the vehicle-treated group subjected to 20 min of ischemia, the neuronal cell density of the CAl subfield ipsilateral to the vehicle injection decreased to 28 ± 37/mm (n = 9), and the density of the contralateral CAl subfield was 22 ± 211mm (n = 9). There was no significant difference in the neuronal cell density between ipsilateral and contralateral to the vehicle treatment. The unilat eral injection of staurosporine at a dose of 10 ng 30 min before induction of ischemia reduced the dam age of the CAl pyramidal cells ipsilateral to the in jection (Fig. 3) . The CAl pyramidal cell density ip silateral to the staurosporine i�ection was 78 ± 60/ mm (n = 9), which was statistically significant (p < 0. 001) compared to the vehicle-treated ischemia group (ipsilateral to the vehicle injection). How ever, the CAl pyramidal cell density contralateral to the staurosporine treatment was not different from that in the vehicle-treated ischemia group both ipsi and contralateral to the injection. In contrast to the protective effect of staurosporine administered 30 min before induction of ischemia, staurosporine treatments 10 or 180 min after recirculation failed to prevent the loss of CAl pyramidal cells (Table 2) .
Cellular distribution (Fig. 4) .
The intracellular amount of staurosporine reached a peak 15 min after the I-h incubation, with little change thereafter. The intracellular concentra tion was >900 nM (packed cell volume). Similar changes were observed in the extracellular amount of staurosporine, except that the peak was reached 2 h after incubation.
DISCUSSION
Staurosporine administered topically to the CAl subfield preceding a brief period of forebrain isch emia was effective in protecting against CAl pyra midal cell damage in both rats and gerbils. It pene trated into the cells. Staurosporine, a microbial al kaloid that has been known to have antifungal activity (Omura et al., 1977) , was found to inhibit markedly phospholipid/Ca 2 + -dependent PKC in the rat brain (Tamaoki et al., 1986) . The IC50 values of staurosporine against PKC, cyclic AMP-dependent protein kinase, and cyclic GMP-dependent protein kinase were 1.8, 23, and 31 nM, respectively. The IC50 values of K-252a, another PKC inhibitor, against PKC, cyclic AMP-dependent protein ki nase, and cyclic GMP-dependent protein kinase were 33, 72, and 87 nM, respectively (Nakanishi et aI., 1988) . Staurosporine is a more potent inhibitor of PKC than other PKC inhibitors, such as K-252b (Kase et al., 1987) , H-7 (Hidaka and Hagiwara, 1987) , trifluoperazine (Schatzman et al., 198 1) , chlorpromazine (Mori et al., 1980) , and polymyxin B (Mazzei et al., 1982) . K-252a (10 ng) but not K-252b (up to a dose of 100 ng) protected against py ramidal cell loss (Yoshidomi et al., 1989) . Taken together, these findings indicate that staurosporine plays its neuroprotective role by the inllibition of PKC. In contrast, cyclic AMP-and cyclic GMP dependent protein kinase inhibitors KT5720 (Kj = 60 nM; Kase et al., 1987) and KT5822 (Kj = 2.4 nM; Kase et aI., 1987) ). However, the possibility exists that KT5720, KT5822, and W-7 could not reach a "therapeutic" intracellular concentration in the present condition.
Marked changes in the intracellular localization of PKC were reported after global ischemia in the J Cereb Blood Flow Metab, Vol. 10, No. 5, 1990
near-term rat, showing translocation of PKC from the cytosol to the particulate membrane fraction (Louis et al., 1988) . , using the same rat model as the present study, reported that phorbol ester binding sites in the rat CAl subfield increased 1-12 h after the recirculation period. The excitatory amino acid released during and/or after ischemia may play a role in the translocation of PKC, since glutamate can translocate PKC from the cytosol to the membrane fraction (Vaccarino et at., 1987) . Moreover, factors affecting enzyme activity and translocation (Kraft and Anderson, 1983 ; Go- , 1986) are noticed during and after ischemia. Calcium deposits were accumulated in the CAl pyramidal cells after ischemia (Simon et aI. , 1984) . Hydrolysis of phosphoinositides into di acylglycerol and inositol phosphate after ischemia (Abe et al., 1987) may also enhance PKC activity.
The neuroprotective effect of staurosporine sug- . , , gests that PKC plays a crucial role in the postisch ernie modulation of neuronal activity in the hippoc ampus (Miller, 1986) This suggests that PKC-mediated processes that oc cur during and/or shortly after recirculation lead to subsequent events that ultimately determine the fate of pyramidal cells.
In the gerbil, preischemic administration of 10 ng staurosporine protected 82% of the CAl pyramidal cells. In contrast, in the rat ischemia model, stau rosporine at 10 ng afforded only a 47% neuropro tection of CAl pyramidal cells. The distinction in the staurosporine effect may be explained partly by the difference in animal species (Onodera and Kogure, 1988) . Since involvement of the hippocam pal formation in the seizure activities characteristic of the gerbil has been reported (Paul et aI., 198 1; Peterson et aI., 1985) , staurosporine might be more protective in the gerbil by an "anticonvulsive" ef fect. In general, neuroprotection of postischemic CAl neurons by drugs has been more pronounced in gerbil ischemia models than rat models.
In conclusion, preischemic administration of a during the early recirculation period. The mecha nisms that finally determine the fate of pyramidal cells remain to be clarified.
